{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:16:55Z","timestamp":1760015815068,"version":"3.41.2"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02290","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T06:07:53Z","timestamp":1569391673000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection"],"prefix":"10.3389","volume":"10","author":[{"given":"Antonella","family":"Cerino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalila","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Oliviero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Varchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario U.","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"B1","unstructured":"Global Hepatitis Report.2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1056\/NEJM198010093031501","article-title":"Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States","volume":"303","author":"Szmuness","year":"1980","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/hep.29323","article-title":"Hepatitis B cure: from discovery to regulatory approval","volume":"66","author":"Lok","year":"2017","journal-title":"Hepatology."},{"key":"B4","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1128\/JVI.70.10.7092-7102.1996","article-title":"Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients","volume":"70","author":"Rehermann","year":"1996","journal-title":"J Virol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1172\/JCI116950","article-title":"Hepatitis B virus persistence after recovery from acute viral hepatitis","volume":"93","author":"Michalak","year":"1994","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1003490","DOI":"10.1371\/journal.ppat.1003490","article-title":"CD40 activation rescues antiviral CD8(+) T cells from PD-1-mediated exhaustion","volume":"9","author":"Isogawa","year":"2013","journal-title":"PLoS Pathog."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/S0140-6736(18)31865-8","article-title":"Chronic hepatitis B virus infection","volume":"392","author":"Seto","year":"2018","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1084\/jem.20011723","article-title":"Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection","volume":"195","author":"Reignat","year":"2002","journal-title":"J Exp Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1016\/j.molimm.2009.04.031","article-title":"HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells","volume":"46","author":"Xu","year":"2009","journal-title":"Mol Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e26315","DOI":"10.1371\/journal.pone.0026315","article-title":"Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells","volume":"6","author":"Vincent","year":"2011","journal-title":"PLoS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J Exp Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1084\/jem.180.3.1159","article-title":"Antigen-independent activation of naive and memory resting T cells by a cytokine combination","volume":"180","author":"Unutmaz","year":"1994","journal-title":"J Exp Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.4049\/jimmunol.178.5.2714","article-title":"PD-1:PD-L1 interactions contribute to the functional suppression of virusspecific CD8+ T lymphocytes in the liver","volume":"178","author":"Maier","year":"2007","journal-title":"J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","article-title":"Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation","volume":"61","author":"Bengsch","year":"2014","journal-title":"J Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-2003-37586","article-title":"Immune responses in hepatitis B virus infection","volume":"23","author":"Rehermann","year":"2003","journal-title":"Semin Liver Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1084\/jem.188.12.2199","article-title":"The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses","volume":"188","author":"Kalams","year":"1998","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.1128\/JVI.00867-09","article-title":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection","volume":"83","author":"Asabe","year":"2009","journal-title":"J Virol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1084\/jem.193.3.297","article-title":"Impairment of CD4(+) T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants","volume":"193","author":"Ciurea","year":"2001","journal-title":"J Exp Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/infdis\/138.5.625","article-title":"Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial","volume":"138","author":"Grady","year":"1978","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife."},{"key":"B23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1055\/s-2006-947298","article-title":"Viral hepatitis and liver transplantation","volume":"26","author":"Sharma","year":"2006","journal-title":"Semin Liver Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hep.27805","article-title":"Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells","volume":"62","author":"Vanwolleghem","year":"2015","journal-title":"Hepatology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1055\/s-0033-1345722","article-title":"Immunosuppression and HBV reactivation","volume":"33","author":"Shibolet","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1200\/JCO.2014.56.7081","article-title":"Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study","volume":"32","author":"Seto","year":"2014","journal-title":"J Clin Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhep.2010.10.016","article-title":"Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections","volume":"55","author":"Oliviero","year":"2011","journal-title":"J Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cellimm.2017.04.012","article-title":"T-bet-expressing B cells during HIV and HCV infections","volume":"321","author":"Knox","year":"2017","journal-title":"Cell Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J Clin Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J Clin Invest."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.07.015","article-title":"Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B","author":"Le Bert","year":"2019","journal-title":"J Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.4049\/jimmunol.1103139","article-title":"IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection","volume":"189","author":"Das","year":"2012","journal-title":"J Immunol."},{"key":"B33","first-page":"295","article-title":"Characteristics of regulatory B cells in patients with chronic hepatitis B virus infection in different immune phases","volume":"23","author":"Wang","year":"2017","journal-title":"Discov Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1385\/0-89603-521-2:451","article-title":"Production of human monoclonal antibodies to hepatitis C virus and their characterization","volume":"19","author":"Mondelli","year":"1999","journal-title":"Methods Mol Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s11684-017-0596-6","article-title":"Human monoclonal antibodies as candidate therapeutics against emerging viruses","volume":"11","author":"Jin","year":"2017","journal-title":"Front Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1126\/science.aah3945","article-title":"Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice","volume":"353","author":"Sok","year":"2016","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.4049\/jimmunol.147.8.2692","article-title":"Identification of an immunodominant B-cell epitope on the hepatitis C virus non structural region defined by human monoclonal antibodies","volume":"147","author":"Cerino","year":"1991","journal-title":"J Immunol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.4049\/jimmunol.151.12.7005","article-title":"A human monoclonal antibody specific for the N-terminus of hepatitis C virus nucleocapsid protein","volume":"151","author":"Cerino","year":"1993","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1128\/JVI.68.8.4829-4836.1994","article-title":"Significance of the immune response to a major, conformational B cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody","volume":"68","author":"Mondelli","year":"1994","journal-title":"J Virol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0125704","DOI":"10.1371\/journal.pone.0125704","article-title":"A human monoclonal antibody against hepatitis B surface antigen with potent neutralizing activity","volume":"10","author":"Cerino","year":"2015","journal-title":"PLoS ONE"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.immuni.2019.04.014","article-title":"Broad and potent neutralizing antibodies recognize the silent face of the HIV envelope","volume":"50","author":"Schoofs","year":"2019","journal-title":"Immunity."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.4049\/jimmunol.1502061","article-title":"Clearing persistent extracellular antigen of hepatitis B virus: an immunomodulatory strategy to reverse tolerance for an effective therapeutic vaccination","volume":"196","author":"Zhu","year":"2016","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/0140-6736(90)93069-2","article-title":"Monoclonal antibody to HBsAg for chronic hepatitis B virus infection with hypogammaglobulinaemia","volume":"335","author":"Lever","year":"1990","journal-title":"Lancet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1034\/j.1600-0676.2001.021003207.x","article-title":"Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patients","volume":"21","author":"van Nunen","year":"2001","journal-title":"Liver"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00535-016-1189-x","article-title":"Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection","volume":"51","author":"Tsuge","year":"2016","journal-title":"J Gastroenterol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jim.2012.09.006","article-title":"A novel assay for detecting virus-specific antibodies triggering activation of Fc\u03b3 receptors","volume":"387","author":"Corrales-Aguilar","year":"2013","journal-title":"J Immunol Methods."},{"key":"B49","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/gutjnl-2014-308964","article-title":"Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen","volume":"65","author":"Zhang","year":"","journal-title":"Gut. ("},{"key":"B50","doi-asserted-by":"publisher","first-page":"e26738","DOI":"10.7554\/eLife.26738","article-title":"A potent human neutralizing antibody Fc-dependently reduces established HBV infections","volume":"6","author":"Li","year":"2017","journal-title":"Elife."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02290\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T20:58:30Z","timestamp":1695243510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02290\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2019.02290"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02290","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"article-number":"2290"}}